Guardant Health’s Shield Blood Test Now Covered for VA Community Care Beneficiaries
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Business Wire
US veterans and eligible family members now have access to blood test for colorectal cancer screening with no copayBenefit will cover all eligible individuals ages 45-84, representing first coverage beyond Medicare population for Shield PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer (CRC) screening is now covered by a key healthcare insurance program for U.S. veterans. The screening test is covered for patients receiving community care authorized by the U.S. Department of Veterans Affairs (VA) as an in-network benefit, with no copay for average-risk individuals who are age 45 or older.Following Medicare coverage for Shield in August 2024, the VA network coverage is the first for individuals between the ages of 45 and 64. The U.S. Department of Veterans Affairs (VA) Community Care Network (CCN) consists of community-based practitioners who provide veterans with
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health (NASDAQ:GH) had its price target raised by analysts at Mizuho from $100.00 to $120.00. They now have an "outperform" rating on the stock.MarketBeat
- Guardant Health price target raised to $120 from $100 at BofA [Yahoo! Finance]Yahoo! Finance
- Guardant Health (NASDAQ:GH) had its price target raised by analysts at JPMorgan Chase & Co. from $90.00 to $120.00. They now have an "overweight" rating on the stock.MarketBeat
- Guardant Health (NASDAQ:GH) was given a new $155.00 price target on by analysts at Leerink Partners.MarketBeat
- Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
GH
Earnings
- 10/29/25 - Beat
GH
Sec Filings
- 12/15/25 - Form 144
- 12/10/25 - Form 4
- 12/10/25 - Form 4
- GH's page on the SEC website